Australia markets closed

Yuyu Pharma, Inc. (000225.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
4,890.000.00 (0.00%)
At close: 03:03PM KST

Yuyu Pharma, Inc.

94 Biovalley 1-ro
Jecheon-si 27159
South Korea
82 4 3652 7981
https://www.yuyu.co.kr

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Wonsang YuPresident & CEON/AN/AN/A
Jung-Sun ParkManaging Director of Marketing and SalesN/AN/A1959
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Jecheon-si, South Korea.

Corporate governance

Yuyu Pharma, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.